Investing in Healthcare Resource Center - McDermott Will & Emery

INVESTING IN HEALTHCARE & LIFE SCIENCES

RESOURCE CENTER

In the ever-changing landscape of global M&A and deal-making, health and life sciences remain top priorities, offering both growth potential and defensive strategies. In these markets, understanding regulatory and policy shifts is crucial. McDermott’s international health and life sciences team excels in working with our clients to anticipate the impact of changing regulatory, reimbursement and strategic issues on their deals. 

Dive into our international Guide, where we reveal insights on forthcoming legal and regulatory risk, changes to drug approvals and device certification, upcoming AI regulation, telemedicine, merger control and more. This is your roadmap to navigating the complex regulations and seizing opportunities.

EXPLORE BY REGION

Discover the healthcare landscape across Europe and the United States with our dynamic interactive map. Uncover key facts and figures at your fingertips.

Europe

Click on a green country for highlights of its regulations and investment insights.

United States

United States

At a glance:

The United States is focusing on drug pricing negotiation and health equity.

  • Unlike European jurisdictions, the United States has a significant market for private reimbursement of healthcare services.
  • Currently, 43 states and the District of Columbia have private payor laws governing telehealth.
  • The US Food and Drug Administration is considering adapting its regulatory framework to promote the development of safe and effective medical devices that use advanced AI algorithms.
  • Although the COVID-19 public health emergency has ended, certain Medicare reimbursement flexibilities related to telehealth are extended through December 31, 2024.
  • The US Department of Justice and the Office of Inspector General have increased enforcement actions targeting fraud and abuse in the telehealth sector.

GUIDE CONTRIBUTORS

A special thanks to all our contributors who have provided their market-leading knowledge and industry acumen across country jurisdictions.
 

MCDERMOTT WILL & EMERY

 

FRANCE

Emmanuelle Trombe, Anne-France Moreau, Katya Ascher, Camille Michaud, Alice Villagrasa

GERMANY

Stephan Rau, Deniz Tschammler, Jana Grieb, Lea Hachmeister, Katharina Hoffmeister

UNITED KINGDOM

Sharon Lamb, Gary Howes, David Gibson, Pilar Arzuaga, Bella North, Michaela Novakova

UNITED STATES

Dale C. Van Demark, Michael W. Ryan, Rachel Stauffer (McDermott+Consulting), Grayson Dimick
 

CONTRIBUTING FIRMS

 

SCHÖNHERR RECHTSANWÄLTE GMBH / AUSTRIA

Dr. Andreas Natterer, Iliyana Sirakova

BECH BRUUN / DENMARK

Martin Dræbye Gantzhorn, Emil Kjeldahl Bjerregaard Bjerrum, Amalie Biltoft

PORTOLANO CAVALLO STUDIO LEGALE / ITALY

Elisa Stefanini, Luca Gambini

HOUTHOFF / NETHERLANDS

Greetje van Heezik, Jori de Goffau, Freeke Heijne

WARDYŃSKI & PARTNERS / POLAND

Joanna Krakowiak

GÓMEZ-ACEBO & POMBO ABOGADOS, S. L. P. / SPAIN

Irene Fernández Puyol

WALDER WYSS LTD. / SWITZERLAND

Dr. Michael Isler, Anne-Catherine Cardinaux